AI Buyer Insights:

● Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

● Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

● Michelin, an e2open customer evaluated Oracle Transportation Management

● Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

● Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

● Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

● Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

● Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

● Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

● Michelin, an e2open customer evaluated Oracle Transportation Management

● Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

● Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

● Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

● Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Aimmune Therapeutics, Inc Tech Stack and Enterprise Applications

Aimmune Therapeutics, Inc CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
TikaMobile Legacy TikaPharma Customer Engagement CRM n/a 2016 2016
In 2016 Aimmune Therapeutics, Inc implemented TikaPharma to support Customer Engagement. The implementation used TikaPharma as a cloud-hosted, mobile-first Customer Engagement application provisioned to patient support, clinical operations, and commercial teams to centralize patient outreach and communication workflows and to standardize engagement touchpoints across patient journeys. TikaPharma was configured with modules aligned to Customer Engagement functional patterns, including campaign and outreach management, automated appointment and dosing reminders, secure messaging with consent-aware content delivery, and structured adverse event reporting workflows. Governance emphasized operational ownership by patient support and clinical operations, role based access controls, standardized engagement playbooks, and a phased internal rollout to align processes and reporting with centralized engagement operations.
Marketing Automation CRM 2017 2017
Sales Automation, CRM, Sales Engagement CRM 2021 2021
Aimmune Therapeutics, Inc AI-Powered Application
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Rocket.chat Legacy Rocket.chat Chatbots and Conversational AI AI-Powered Application n/a 2018 2018
In 2018, Aimmune Therapeutics, Inc deployed Rocket.chat on their website as a customer facing conversational interface. Rocket.chat is implemented as an embedded web chat instance delivering Chatbots and Conversational AI capabilities for real time messaging, visitor engagement, and scripted bot responses. The implementation is scoped to website customer engagement and support functions, enabling live messaging, automated reply workflows, session handling, and role based moderation through Rocket.chat administrative controls. Functional configuration centers on web widget deployment, channel management, canned responses, and bot orchestration to support conversational workflows. Architecturally the setup follows a browser embedded widget model where the client side UI interacts with a Rocket.chat back end to orchestrate message routing and conversational sessions. This pattern positions Rocket.chat as the Chatbots and Conversational AI interface for marketing and support touchpoints on the Aimmune Therapeutics, Inc website.
Aimmune Therapeutics, Inc Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2021 2021
In 2021, Aimmune Therapeutics, Inc implemented Microsoft 365. The Microsoft 365 deployment is referenced on the company website and functions as the organizations primary Collaboration platform for the 350 employee, United States based life sciences company. The implementation targets cloud hosted productivity and collaboration capabilities to support corporate communication and document management workflows. Functionally the deployment leverages standard Microsoft 365 Collaboration capabilities, including enterprise email, real time communication and cloud document collaboration through Office applications, Teams, SharePoint and OneDrive as core components of the suite. Corporate IT governs the tenant with configuration for access controls, identity management and content permissioning to enforce lifecycle workflows for document sharing and internal collaboration across departments, with the Microsoft 365 tenant surfaced on the public website.
Aimmune Therapeutics, Inc Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application, Web and Enterprise Search Content Management 2020 2020
Aimmune Therapeutics, Inc PaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Transactional Email PaaS 2016 2016
Transactional Email PaaS 2019 2019
Aimmune Therapeutics, Inc IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2015 2015
Application Hosting and Computing Services IaaS 2017 2017
Content Delivery Network IaaS 2019 2019
Aimmune Therapeutics, Inc CyberSecurity
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Secure Email Gateways (SEGs) CyberSecurity 2020 2020

IT Decision Makers and Key Stakeholders at Aimmune Therapeutics, Inc

First Name Last Name Title Function Department Email Phone
No data found

Apps Being Evaluated by Aimmune Therapeutics, Inc Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Aimmune Therapeutics, Inc IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Aimmune Therapeutics, Inc digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Aimmune Therapeutics, Inc Technographics
Aimmune Therapeutics, Inc is a Life Sciences organization based in United States, with around 350 employees and annual revenues of $30.0 million.
Aimmune Therapeutics, Inc operates a diverse technology stack with applications such as TikaPharma, Rocket.chat and Microsoft 365, covering areas like Customer Engagement, Chatbots and Conversational AI and Collaboration.
Aimmune Therapeutics, Inc has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as TikaMobile, Rocket.chat and Microsoft.
Aimmune Therapeutics, Inc recently adopted applications including Salesforce Sales Cloud in 2021, Microsoft 365 in 2021 and Algolia Search in 2020, highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Aimmune Therapeutics, Inc’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates Aimmune Therapeutics, Inc’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Aimmune Therapeutics, Inc technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.